相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Origin and evolution of pathogenic coronaviruses
Jie Cui et al.
NATURE REVIEWS MICROBIOLOGY (2019)
MERS, SARS and other coronaviruses as causes of pneumonia
Yudong Yin et al.
RESPIROLOGY (2018)
Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus
Yao Deng et al.
EMERGING MICROBES & INFECTIONS (2018)
Current understanding of middle east respiratory syndrome coronavirus infection in human and animal models
Yanqun Wang et al.
JOURNAL OF THORACIC DISEASE (2018)
High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia
Abeer N. Alshukairi et al.
MBIO (2018)
MERS-CoV spike protein: a key target for antivirals
Lanying Du et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
Protective T Cell Responses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus-Derived CD8+ T Cell Epitopes and Host MHC
William J. Liu et al.
JOURNAL OF IMMUNOLOGY (2017)
Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants
Wanbo Tai et al.
JOURNAL OF VIROLOGY (2017)
A mouse model for MERS coronavirus-induced acute respiratory distress syndrome
Adam S. Cockrell et al.
NATURE MICROBIOLOGY (2017)
Human Neutralizing Monoclonal Antibody Inhibition of Middle East Respiratory Syndrome Coronavirus Replication in the Common Marmoset
Zhe Chen et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Permissivity of Dipeptidyl Peptidase 4 Orthologs to Middle East Respiratory Syndrome Coronavirus Is Governed by Glycosylation and Other Complex Determinants
Kayla M. Peck et al.
JOURNAL OF VIROLOGY (2017)
Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice
Kun Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection
Lan Jiaming et al.
VACCINE (2017)
Rapid development of vaccines against emerging pathogens: The replication-deficient simian adenovirus platform technology
Sarah C. Gilbert et al.
VACCINE (2017)
DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice
Hang Chi et al.
VACCINE (2017)
Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein
Sawsan S. Al-amri et al.
SCIENTIFIC REPORTS (2017)
Comparative pathology of rhesus macaque and common marmoset animal models with Middle East respiratory syndrome coronavirus
Pin Yu et al.
PLOS ONE (2017)
Domestic Pig Unlikely Reservoir for MERS-CoV
Emmie de Wit et al.
EMERGING INFECTIOUS DISEASES (2017)
Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways
Hin Chu et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Spatiotemporal interplay of severe acute respiratory syndrome coronavirus and respiratory mucosal cells drives viral dissemination in rhesus macaques
L. Liu et al.
MUCOSAL IMMUNOLOGY (2016)
An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels
Bart L. Haagmans et al.
SCIENCE (2016)
Dipeptidyl Peptidase 4 Distribution in the Human Respiratory Tract Implications for the Middle East Respiratory Syndrome
David K. Meyerholz et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Airway Memory CD4+ T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses
Jincun Zhao et al.
IMMUNITY (2016)
Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
Nan Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Differential Expression of the Middle East Respiratory Syndrome Coronavirus Receptor in the Upper Respiratory Tracts of Humans and Dromedary Camels
W. Widagdo et al.
JOURNAL OF VIROLOGY (2016)
SARS and MERS: recent insights into emerging coronaviruses
Emmie de Wit et al.
NATURE REVIEWS MICROBIOLOGY (2016)
MERS-CoV vaccine candidates in development: The current landscape
Kayvon Modjarrad
VACCINE (2016)
Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates
Qidi Wang et al.
ACS INFECTIOUS DISEASES (2016)
MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2
Man-Lung Yeung et al.
NATURE MICROBIOLOGY (2016)
Experimental Infection and Response to Rechallenge of Alpacas with Middle East Respiratory Syndrome Coronavirus
Gary Crameri et al.
EMERGING INFECTIOUS DISEASES (2016)
Infection, Replication, and Transmission of Middle East Respiratory Syndrome Coronavirus in Alpacas
Danielle R. Adney et al.
EMERGING INFECTIOUS DISEASES (2016)
Response to Emergence of Middle East Respiratory Syndrome Coronavirus, Abu Dhabi, United Arab Emirates, 2013-2014
Farida Ismail Al Hosani et al.
EMERGING INFECTIOUS DISEASES (2016)
Protease inhibitors targeting coronavirus and filovirus entry
Yanchen Zhou et al.
ANTIVIRAL RESEARCH (2015)
A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein
Yan Li et al.
CELL RESEARCH (2015)
Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015
H. Y. Park et al.
EUROSURVEILLANCE (2015)
Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset
Jasper Fuk-Woo Chan et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Asymptomatic Middle East Respiratory Syndrome Coronavirus Infection in Rabbits
Bart L. Haagmans et al.
JOURNAL OF VIROLOGY (2015)
Middle East respiratory syndrome
Alimuddin Zumla et al.
LANCET (2015)
A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence
Vineet D. Menachery et al.
NATURE MEDICINE (2015)
2014 MERS-CoV Outbreak in Jeddah - A Link to Health Care Facilities
Ikwo K. Oboho et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus
Davide Corti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease
Reed F. Johnson et al.
VIROLOGY (2015)
Evaluation of candidate vaccine approaches for MERS-CoV
Lingshu Wang et al.
NATURE COMMUNICATIONS (2015)
Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge
Jiaming Lan et al.
EBIOMEDICINE (2015)
An Observational, Laboratory-Based Study of Outbreaks of Middle East Respiratory Syndrome Coronavirus in Jeddah and Riyadh, Kingdom of Saudi Arabia, 2014
Christian Drosten et al.
CLINICAL INFECTIOUS DISEASES (2015)
Receptor Recognition Mechanisms of Coronaviruses: a Decade of Structural Studies
Fang Li
JOURNAL OF VIROLOGY (2015)
Multi-Organ Damage in Human Dipeptidyl Peptidase 4 Transgenic Mice Infected with Middle East Respiratory Syndrome-Coronavirus
Guangyu Zhao et al.
PLOS ONE (2015)
Clinical Course and Outcomes of Critically Ill Patients With Middle East Respiratory Syndrome Coronavirus Infection
Yaseen M. Arabi et al.
ANNALS OF INTERNAL MEDICINE (2014)
Hospital-Associated Outbreak of Middle East Respiratory Syndrome Coronavirus: A Serologic, Epidemiologic, and Clinical Description
Mohammad Mousa Al-Abdallat et al.
CLINICAL INFECTIOUS DISEASES (2014)
Current advancements and potential strategies in the development of MERS-CoV vaccines
Naru Zhang et al.
EXPERT REVIEW OF VACCINES (2014)
Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia
Mustafa Saad et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2014)
Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus
Christopher M. Coleman et al.
JOURNAL OF GENERAL VIROLOGY (2014)
Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays
Brit J. Hart et al.
JOURNAL OF GENERAL VIROLOGY (2014)
An Animal Model of MERS Produced by Infection of Rhesus Macaques With MERS Coronavirus
Yanfeng Yao et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Active Replication of Middle East Respiratory Syndrome Coronavirus and Aberrant Induction of Inflammatory Cytokines and Chemokines in Human Macrophages: Implications for Pathogenesis
Jie Zhou et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Adenosine Deaminase Acts as a Natural Antagonist for Dipeptidyl Peptidase 4-Mediated Entry of the Middle East Respiratory Syndrome Coronavirus
V. Stalin Raj et al.
JOURNAL OF VIROLOGY (2014)
Host Species Restriction of Middle East Respiratory Syndrome Coronavirus through Its Receptor, Dipeptidyl Peptidase 4
Neeltje van Doremalen et al.
JOURNAL OF VIROLOGY (2014)
Receptor Variation and Susceptibility to Middle East Respiratory Syndrome Coronavirus Infection
Arlene Barlan et al.
JOURNAL OF VIROLOGY (2014)
Mouse Dipeptidyl Peptidase 4 Is Not a Functional Receptor for Middle East Respiratory Syndrome Coronavirus Infection
Adam S. Cockrell et al.
JOURNAL OF VIROLOGY (2014)
A Conformation-Dependent Neutralizing Monoclonal Antibody Specifically Targeting Receptor-Binding Domain in Middle East Respiratory Syndrome Coronavirus Spike Protein
Lanying Du et al.
JOURNAL OF VIROLOGY (2014)
Evidence for Camel-to-Human Transmission of MERS Coronavirus
Esam I. Azhar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Rapid generation of a mouse model for Middle East respiratory syndrome
Jincun Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice
Eun Kim et al.
VACCINE (2014)
Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response
Hin Chu et al.
VIROLOGY (2014)
Middle East Respiratory Syndrome Coronavirus Infection in Dromedary Camels in Saudi Arabia
Abdulaziz N. Alagaili et al.
MBIO (2014)
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
Lu Lu et al.
NATURE COMMUNICATIONS (2014)
Infection with MERS-CoV Causes Lethal Pneumonia in the Common Marmoset
Darryl Falzarano et al.
PLOS PATHOGENS (2014)
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
Nianshuang Wang et al.
CELL RESEARCH (2013)
Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) - possible lessons from a systematic review of SARS-CoV therapy
Hisham Momattin et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2013)
Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment
Susanna K. P. Lau et al.
JOURNAL OF GENERAL VIROLOGY (2013)
Complete Protection against Severe Acute Respiratory Syndrome Coronavirus-Mediated Lethal Respiratory Disease in Aged Mice by Immunization with a Mouse-Adapted Virus Lacking E Protein
Craig Fett et al.
JOURNAL OF VIROLOGY (2013)
Middle East Respiratory Syndrome Coronavirus Infection Mediated by the Transmembrane Serine Protease TMPRSS2
Kazuya Shirato et al.
JOURNAL OF VIROLOGY (2013)
Structure of the Fusion Core and Inhibition of Fusion by a Heptad Repeat Peptide Derived from the S Protein of Middle East Respiratory Syndrome Coronavirus
Jing Gao et al.
JOURNAL OF VIROLOGY (2013)
Tropism of and Innate Immune Responses to the Novel Human Betacoronavirus Lineage C Virus in Human Ex Vivo Respiratory Organ Cultures
Renee W. Y. Chan et al.
JOURNAL OF VIROLOGY (2013)
Identification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Development
Lanying Du et al.
JOURNAL OF VIROLOGY (2013)
Crystal Structure of the Receptor-Binding Domain from Newly Emerged Middle East Respiratory Syndrome Coronavirus
Yaoqing Chen et al.
JOURNAL OF VIROLOGY (2013)
The Spike Protein of the Emerging Betacoronavirus EMC Uses a Novel Coronavirus Receptor for Entry, Can Be Activated by TMPRSS2, and Is Targeted by Neutralizing Antibodies
Stefanie Gierer et al.
JOURNAL OF VIROLOGY (2013)
Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study
Abdullah Assiri et al.
LANCET INFECTIOUS DISEASES (2013)
Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor
Xing-Yi Ge et al.
NATURE (2013)
Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
Guangwen Lu et al.
NATURE (2013)
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
V. Stalin Raj et al.
NATURE (2013)
Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques
Darryl Falzarano et al.
NATURE MEDICINE (2013)
A decade after SARS: strategies for controlling emerging coronaviruses
Rachel L. Graham et al.
NATURE REVIEWS MICROBIOLOGY (2013)
Hospital Outbreak of Middle East Respiratory Syndrome Coronavirus
Abdullah Assiri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Pneumonia from Human Coronavirus in a Macaque Model
Vincent J. Munster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Does Not Replicate in Syrian Hamsters
Emmie de Wit et al.
PLOS ONE (2013)
Engineering a Replication-Competent, Propagation-Defective Middle East Respiratory Syndrome Coronavirus as a Vaccine Candidate
Fernando Almazan et al.
MBIO (2013)
Molecular Determinants of Severe Acute Respiratory Syndrome Coronavirus Pathogenesis and Virulence in Young and Aged Mouse Models of Human Disease
Matthew Frieman et al.
JOURNAL OF VIROLOGY (2012)
A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease
Rachel L. Graham et al.
NATURE MEDICINE (2012)
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Ali Moh Zaki et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Effects of respiratory syncytial virus infection and major basic protein derived from eosinophils in pulmonary alveolar epithelial cells (A549)
Taisei Ishioka et al.
CELL BIOLOGY INTERNATIONAL (2011)
Age-related increases in PGD2 expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice
Jincun Zhao et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Fully Human Monoclonal Antibody Directed to Proteolytic Cleavage Site in Severe Acute Respiratory Syndrome (SARS) Coronavirus S Protein Neutralizes the Virus in a Rhesus Macaque SARS Model
Tohru Miyoshi-Akiyama et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response
Meagan Bolles et al.
JOURNAL OF VIROLOGY (2011)
Epithelial Cells Lining Salivary Gland Ducts Are Early Target Cells of Severe Acute Respiratory Syndrome Coronavirus Infection in the Upper Respiratory Tracts of Rhesus Macaques
Li Liu et al.
JOURNAL OF VIROLOGY (2011)
T Cell Responses Are Required for Protection from Clinical Disease and for Virus Clearance in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice
Jincun Zhao et al.
JOURNAL OF VIROLOGY (2010)
Procyanidins and butanol extract of Cinnamomi Cortex inhibit SARS-CoV infection
Min Zhuang et al.
ANTIVIRAL RESEARCH (2009)
SARS vaccines: where are we?
Rachel L. Roper et al.
EXPERT REVIEW OF VACCINES (2009)
The spike protein of SARS-CoV - a target for vaccine and therapeutic development
Lanying Du et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Evasion by Stealth: Inefficient Immune Activation Underlies Poor T Cell Response and Severe Disease in SARS-CoV-Infected Mice
Jincun Zhao et al.
PLOS PATHOGENS (2009)
Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines
Raymond H. See et al.
JOURNAL OF GENERAL VIROLOGY (2008)
T cell responses to whole SARS coronavirus in humans
Chris Ka-fai Li et al.
JOURNAL OF IMMUNOLOGY (2008)
Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge
Barry Rockx et al.
JOURNAL OF VIROLOGY (2008)
Engineering attenuated virus vaccines by controlling replication fidelity
Marco Vignuzzi et al.
NATURE MEDICINE (2008)
Pathology of experimental SARS coronavirus infection in cats and ferrets
J. M. A. Van den Brand et al.
VETERINARY PATHOLOGY (2008)
An immunosuppressed Syrian golden hamster model for SARS-CoV infection
Scott R. Schaecher et al.
VIROLOGY (2008)
Rhesus angiotensin converting enzyme 2 supports entry of severe acute respiratory syndrome coronavirus in Chinese macaques
Yunxin Chen et al.
VIROLOGY (2008)
Pathogenetic mechanisms of severe acute respiratory syndrome
Yong Guo et al.
VIRUS RESEARCH (2008)
Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease
Luis Enjuanes et al.
VIRUS RESEARCH (2008)
MyD88 Is Required for Protection from Lethal Infection with a Mouse-Adapted SARS-CoV
Timothy Sheahan et al.
PLOS PATHOGENS (2008)
Amino acid substitutions in the S2 subunit of mouse hepatitis virus variant V51 encode determinants of host range expansion
Willie C. McRoy et al.
JOURNAL OF VIROLOGY (2008)
Specific asparagine-linked glycosylation sites are critical for DC-SIGN- and L-SIGN-Mediated severe acute respiratory syndrome coronavirus entry
Dong P. Han et al.
JOURNAL OF VIROLOGY (2007)
Severe acute respiratory syndrome coronavirus infection in vaccinated ferrets
Miriam E. R. Darnell et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Protection from infection with severe acute respiratory syndrome coronavirus in a chinese hamster model by equine neutralizing F(ab')2
Deyan Luo et al.
VIRAL IMMUNOLOGY (2007)
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies
Zhongyu Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse®
Melissa Coughlin et al.
VIROLOGY (2007)
Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human angiotensin-converting enzyme 2 virus receptor
Chien-Te K. Tseng et al.
JOURNAL OF VIROLOGY (2007)
Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcγRII- dependent entry into B cells in vitro
Yin Wing Kam et al.
VACCINE (2007)
Pathology and pathogenesis of severe acute respiratory syndrome
Jiang Gu et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Core structure of S2 from the human coronavirus NL63 spike Glycoprotein
Qi Zheng et al.
BIOCHEMISTRY (2006)
Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants
Damon Deming et al.
PLOS MEDICINE (2006)
Human monoclonal antibody combination against SARS coronavirus: Synergy and coverage of escape mutants
Jan ter Meulen et al.
PLOS MEDICINE (2006)
Is there an ideal animal model for SARS?
Kanta Subbarao et al.
TRENDS IN MICROBIOLOGY (2006)
Conformational states of the severe acute respiratory syndrome coronavirus spike protein ectodomain
Fang Li et al.
JOURNAL OF VIROLOGY (2006)
Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: Implication for vaccine design
Yuxian He et al.
JOURNAL OF VIROLOGY (2006)
A single amino acid substitution (R441A) in the receptor-binding domain of SARS coronavirus spike protein disrupts the antigenic structure and binding activity
YX He et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein
Yuxian He et al.
JOURNAL OF IMMUNOLOGY (2006)
Cynomolgus macaque as an animal model for severe acute respiratory syndrome
James V. Lawler et al.
PLOS MEDICINE (2006)
The expression of membrane protein augments the specific responses induced by SARS-CoV nucleocapsid DNA immunization
SQ Shi et al.
MOLECULAR IMMUNOLOGY (2006)
SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens
V Gupta et al.
VIROLOGY (2006)
Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus
RH See et al.
JOURNAL OF GENERAL VIROLOGY (2006)
Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters
A Roberts et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
SARS: clinical presentation, transmission, pathogenesis and treatment options
PKS Chan et al.
CLINICAL SCIENCE (2006)
A double-inactivated whole virus candidate SARS coronavirus vaccine
M Spruth et al.
VACCINE (2006)
SARS: Systematic review of treatment effects
Lauren J. Stockman et al.
PLOS MEDICINE (2006)
SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus
PCY Woo et al.
VACCINE (2005)
A serological survey on neutralizing antibody titer of SARS convalescent sera
JS Zhang et al.
JOURNAL OF MEDICAL VIROLOGY (2005)
Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (SARS-CoV)
SC Lai et al.
JOURNAL OF BIOMEDICAL SCIENCE (2005)
Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine
SU Kapadia et al.
VIROLOGY (2005)
Structure of SARS coronavirus spike receptor-binding domain complexed with receptor
F Li et al.
SCIENCE (2005)
Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in rhesus macaque
BJ Li et al.
NATURE MEDICINE (2005)
Screening and identification of linear B-cell epitopes and entry-blocking peptide of severe acute respiratory syndrome (SARS)-associated coronavirus using synthetic overlapping peptide library
HB Hu et al.
JOURNAL OF COMBINATORIAL CHEMISTRY (2005)
Identification of two critical amino acid residues of the severe acute respiratory syndrome coronavirus spike protein for its variation in zoonotic tropism transition via a double substitution strategy
XX Qu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
SARS vaccine protective in mice
K Stadler et al.
EMERGING INFECTIOUS DISEASES (2005)
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury
K Kuba et al.
NATURE MEDICINE (2005)
Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus
TC Greenough et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus
C Qin et al.
JOURNAL OF PATHOLOGY (2005)
A molecular docking model of SARS-CoV S1 protein in complex with its receptor, human ACE2
Y Zhang et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2005)
Identification and characterization of the putative fusion peptide of the severe acute respiratory syndrome-associated coronavirus spike protein
B Sainz et al.
JOURNAL OF VIROLOGY (2005)
Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans
A Roberts et al.
JOURNAL OF VIROLOGY (2005)
Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2
WH Li et al.
EMBO JOURNAL (2005)
Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein
H Bisht et al.
VIROLOGY (2005)
Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: Importance for designing SARS vaccines
YX He et al.
VIROLOGY (2005)
Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets
M Czub et al.
VACCINE (2005)
Amino acids 1055 to 1192 in the S2 region of severe acute respiratory syndrome coronavirus S protein induce neutralizing antibodies: Implications for the development of vaccines and antiviral agents
CT Keng et al.
JOURNAL OF VIROLOGY (2005)
Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region
ZW Chen et al.
JOURNAL OF VIROLOGY (2005)
Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice
TC Greenough et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates
DL Wu et al.
JOURNAL OF VIROLOGY (2005)
Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus
EN van den Brink et al.
JOURNAL OF VIROLOGY (2005)
Severe acute respiratory syndrome (SARS): A year in review
DA Skowronski et al.
ANNUAL REVIEW OF MEDICINE (2005)
Acute renal impairment in coronavirus-associated severe acute respiratory syndrome
KH Chu et al.
KIDNEY INTERNATIONAL (2005)
Severe acute respiratory syndrome coronavirus infection of Golden Syrian hamsters
A Roberts et al.
JOURNAL OF VIROLOGY (2005)
Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection
WJ Chen et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2004)
Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice
H Bisht et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
ZY Yang et al.
NATURE (2004)
Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice
K Subbarao et al.
JOURNAL OF VIROLOGY (2004)
Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors
SW Liu et al.
LANCET (2004)
Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association
JH Sui et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2
SK Wong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Resolution of primary severe acute respiratory syndrome-associated coronavirus infection requires Stat1
RJ Hogan et al.
JOURNAL OF VIROLOGY (2004)
Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection
YC Nie et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice
WG Glass et al.
JOURNAL OF IMMUNOLOGY (2004)
An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus
E Traggiai et al.
NATURE MEDICINE (2004)
Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys
J McAuliffe et al.
VIROLOGY (2004)
Structural basis for coronavirus-mediated membrane fusion - Crystal structure of mouse hepatitis virus spike protein fusion core
YH Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein
KH Yuan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies
T Zhou et al.
JOURNAL OF VIROLOGY (2004)
The life cycle of SARS coronavirus in Vero E6 cells
QF Zhang et al.
JOURNAL OF MEDICAL VIROLOGY (2004)
Mice susceptible to SARS coronavirus
DE Wentworth et al.
EMERGING INFECTIOUS DISEASES (2004)
Crystal structure of severe acute respiratory syndrome coronavirus spike protein fusion core
YH Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS
A Bukreyev et al.
LANCET (2004)
Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets
J ter Meulen et al.
LANCET (2004)
CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus
SA Jeffers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets
H Weingartl et al.
JOURNAL OF VIROLOGY (2004)
Severe acute respiratory syndrome coroavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides
BJ Bosch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
pH-dependent entry of Severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN
ZY Yang et al.
JOURNAL OF VIROLOGY (2004)
S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients
H Hofmann et al.
JOURNAL OF VIROLOGY (2004)
Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways
YQ Ding et al.
JOURNAL OF PATHOLOGY (2004)
Macaque model for severe acute respiratory syndrome
T Rowe et al.
JOURNAL OF VIROLOGY (2004)
Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2
WH Li et al.
JOURNAL OF VIROLOGY (2004)
The SARS-CoV S glycoprotein: expression and functional characterization
XD Xiao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
WH Li et al.
NATURE (2003)
SARS virus infection of cats and ferrets
BEE Martina et al.
NATURE (2003)
Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003
NS Zhong et al.
LANCET (2003)
Isolation and characterization of viruses related to the SARS coronavirus from animals in Southern China
Y Guan et al.
SCIENCE (2003)
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome
T Kuiken et al.
LANCET (2003)
The genome sequence of the SARS-associated coronavirus
MA Marra et al.
SCIENCE (2003)
Characterization of a novel coronavirus associated with severe acute respiratory syndrome
PA Rota et al.
SCIENCE (2003)
A novel coronavirus associated with severe acute respiratory syndrome
TG Ksiazek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A major outbreak of severe acute respiratory syndrome in Hong Kong
N Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
C Drosten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Aetiology -: Koch's postulates fulfilled for SARS virus
RAM Fouchier et al.
NATURE (2003)
分享论文
